Growth Metrics

Quest Diagnostics (DGX) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $5.2 billion.

  • Quest Diagnostics' Non-Current Debt fell 844.55% to $5.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 billion, marking a year-over-year decrease of 844.55%. This contributed to the annual value of $5.6 billion for FY2024, which is 2732.43% up from last year.
  • Latest data reveals that Quest Diagnostics reported Non-Current Debt of $5.2 billion as of Q3 2025, which was down 844.55% from $5.2 billion recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Non-Current Debt ranged from a high of $5.9 billion in Q1 2025 and a low of $3.8 billion during Q2 2023
  • For the 5-year period, Quest Diagnostics' Non-Current Debt averaged around $4.4 billion, with its median value being $4.0 billion (2021).
  • Over the last 5 years, Quest Diagnostics' Non-Current Debt had its largest YoY gain of 5399.58% in 2025, and its largest YoY loss of 844.55% in 2025.
  • Over the past 5 years, Quest Diagnostics' Non-Current Debt (Quarter) stood at $4.0 billion in 2021, then decreased by 0.8% to $4.0 billion in 2022, then increased by 10.86% to $4.4 billion in 2023, then rose by 27.32% to $5.6 billion in 2024, then fell by 7.91% to $5.2 billion in 2025.
  • Its Non-Current Debt was $5.2 billion in Q3 2025, compared to $5.2 billion in Q2 2025 and $5.9 billion in Q1 2025.